InflaRx (IFRX) Interest Income - Deposits (2017 - 2026)
InflaRx's (IFRX) quarterly Interest Income - Deposits came in at $803475.7 in Q2 2026, up 212.18% year-over-year from $257373.7 in Q2 2025, and up 115.73% quarter-over-quarter from $372449.3 in Q1 2026.
Analysis
InflaRx (IFRX) Interest Income - Deposits (2017 - 2026) Analysis & Trends
InflaRx has disclosed Interest Income - Deposits across 10 years of filings, most recently posting $803475.7 for Q2 2026.
- In Q2 2026, Interest Income - Deposits rose 212.18% year-over-year to $803475.7; the TTM figure through Jun 2026 stood at $2.1 million (up 11.65% YoY), while the FY2025 annual figure was $2.0 million, down 18.07% from the prior year.
- Interest Income - Deposits came in at $803475.7 for Q2 2026 at InflaRx, up from $372449.3 in the prior quarter.
- In the past five years, Interest Income - Deposits ranged from a high of $951642.0 in Q1 2024 to a low of $224709.3 in Q2 2022.
- Average Interest Income - Deposits over 5 years is $488505.6, with a median of $426929.0 recorded in 2023.
- Year-over-year, Interest Income - Deposits jumped 1080.03% in 2022 and sank 51.59% in 2025.
- Over 5 years, Interest Income - Deposits stood at $391318.9 in 2022, then climbed by 18.2% to $462539.0 in 2023, then slumped by 41.52% to $270507.4 in 2024, then increased by 29.8% to $351125.6 in 2025, then jumped by 128.83% to $803475.7 in 2026.
- Per Business Quant data, the three most recent Interest Income - Deposits figures were $803475.7 in Q2 2026, $372449.3 in Q1 2026, and $351125.6 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Deposits (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | InflaRx | 139.29 Mn | -44.96 Mn | 2.74 Mn | 803,475.66 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 803,475.66 |
| Mar 31, 2026 | 372,449.31 |
| Dec 31, 2025 | 351,125.58 |
| Sep 30, 2025 | 620,145.15 |
| Jun 30, 2025 | 257,373.67 |
| Mar 31, 2025 | 713,931.85 |
| Dec 31, 2024 | 270,507.45 |
| Sep 30, 2024 | 681,317.81 |
| Jun 30, 2024 | 531,637.86 |
| Mar 31, 2024 | 951,642.04 |
| Dec 31, 2023 | 462,539.04 |
| Sep 30, 2023 | 812,440.11 |
| Jun 30, 2023 | 337,672.19 |
| Mar 31, 2023 | 264,010.96 |
| Dec 31, 2022 | 391,318.94 |
| Sep 30, 2022 | 274,394.80 |
| Jun 30, 2022 | 224,709.33 |
| Mar 31, 2022 | 472,409.90 |
| Dec 31, 2021 | 716,931.17 |
| Sep 30, 2021 | 84,750.66 |